fluorodeoxyglucose f18 has been researched along with azomycin in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.22) | 18.2507 |
2000's | 12 (26.67) | 29.6817 |
2010's | 31 (68.89) | 24.3611 |
2020's | 1 (2.22) | 2.80 |
Authors | Studies |
---|---|
Chang, YS; Chung, JK; Jang, JJ; Jeong, JM; Kim, YJ; Lee, DS; Lee, MC; Lee, YJ | 1 |
Patt, M; Scheunemann, M; Sorger, D; Stöcklin, G | 1 |
Eskola, O; Grénman, R; Grönroos, T; Lehtiö, K; Minn, H; Oikonen, V; Sillanmäki, L; Viljanen, T | 1 |
Bormans, G; Dubois, L; Dupont, P; Flamen, P; Haustermans, K; Landuyt, W; Mortelmans, L; Verbeken, E; Vermaelen, P | 1 |
Burgman, P; Burnazi, E; Cai, S; Finn, RD; Humm, JL; Lewis, JS; Ling, CC; O'Donoghue, JA; Pugachev, A; Ruan, S; Smith-Jones, P; Welch, MJ; Wen, B; Zanzonico, P | 1 |
Campa, J; Carlin, S; Humm, JL; Larson, SM; Ling, CC; Pugachev, A; Ruan, S | 1 |
de Geus-Oei, LF; Heerschap, A; Kaanders, JH; Krabbe, PF; Lok, J; Oyen, WJ; Punt, CJ; Rijpkema, M; Ruers, T; van der Kogel, AJ; van Laarhoven, HW; Wiering, B | 1 |
Bolton, DM; Davis, ID; Lawrentschuk, N; Scott, AM | 1 |
Alber, M; Eschmann, SM; Holzner, F; Paulsen, F; Thorwarth, D | 1 |
Chastagner, P; Fouyssac, F; Karcher, G; Pinel, S; Plenat, F; Poussier, S; Scigliano, S | 1 |
Baumann, M; Bergmann, R; Beuthien-Baumann, B; Brüchner, K; Dörfler, A; Eicheler, W; Hessel, F; Krause, M; Menegakis, A; Schütze, C; van den Hoff, J; Wüllrich, K; Yaromina, A; Zhou, X; Zips, D | 1 |
Busk, M; Bussink, J; Horsman, MR; Jakobsen, S; Overgaard, J; van der Kogel, A | 1 |
Fujibayashi, Y; Fujieda, S; Furukawa, T; Kobayashi, M; Kudo, T; Mori, T; Oh, M; Tanaka, T | 1 |
Higano, S; Iwata, R; Kanamori, M; Kumabe, T; Saito, R; Shibahara, I; Sonoda, Y; Takai, Y; Takanami, K; Tominaga, T; Watanabe, M | 1 |
Bol, A; Christian, N; De Bast, M; Deheneffe, S; Grégoire, V; Labar, D; Lee, JA | 1 |
Humm, JL; Li, XF; Ling, CC; Ma, Y; O'Donoghue, JA; Sun, X | 1 |
Hu, M; Li, L; Yang, G; Yu, J; Zhao, W; Zhu, H | 1 |
Busk, M; Horsman, MR; Jakobsen, S; Mueller-Klieser, W; Overgaard, J; Steiniche, T; Walenta, S | 1 |
Busk, M; Bussink, J; Engelholm, SA; Hansen, AE; Jørgensen, JT; Kjær, A; Kristensen, AT; McEvoy, FJ; van der Kogel, AJ | 1 |
Civelek, AC; Huang, T; Jiang, H; Li, J; Li, XF; Ng, CK; Postel, GC; Shen, B | 1 |
Jans, HS; Kumar, P; Wang, M; Wiebe, LI; Wuest, M; Yang, J | 1 |
Barranger, E; Barré, E; Baruch-Hennequin, V; Delord, M; Delpech, Y; Groheux, D; Hindié, E; Homyrda, L; Schlageter, MH; Thoury, A; Tylski, P; Vercellino, L; Walker, F | 1 |
Dierckx, RA; Halmos, GB; Langedijk, JA; Pruim, J; Roodenburg, JL; van der Laan, BF; Wedman, J | 1 |
Hanzawa, H; Hatano, T; Kuge, Y; Kuno, N; Nishijima, K; Sakamoto, T; Tamaki, N; Zhao, S; Zhao, Y | 1 |
Bollineni, VR; de Groot, EH; Groen, HJ; Kerner, GS; Koole, MJ; Langendijk, JA; Luurtsema, G; Pruim, J; Steenbakkers, RJ; Widder, J; Wiegman, EM; Willemsen, AT | 1 |
Beppu, T; Ehara, S; Fujiwara, S; Iwata, R; Kudo, K; Matsuura, H; Ogasawara, K; Sasaki, M; Sasaki, T; Sera, K; Sugai, T; Takai, Y; Terasaki, K; Uesugi, N; Yamada, N | 1 |
Belloli, S; Brioschi, A; Calderoni, S; Fazio, F; Mauro, A; Monterisi, C; Moresco, RM; Pagani, A; Politi, LS; Raccagni, I; Ronchetti, F; Zara, G; Zenga, F | 1 |
Busk, M; Horsman, MR; Iversen, AB; Jakobsen, S; Ji, X; Lee, DY; Mortensen, LS; Nordsmark, M; Overgaard, J; Raleigh, JR | 1 |
Giraud, P; Servagi-Vernat, S | 1 |
Balkay, L; Emri, M; Goda, K; Juhász, I; Krasznai, Z; Krasznai, ZT; Lajtos, I; Márián, T; Mikecz, P; Miklovicz, T; Németh, E; Szabó, G; Szalóki, G; Trencsényi, G | 1 |
Berndorff, D; Chang, E; Cheng, Z; Ellinghaus, P; Gambhir, SS; Gekeler, V; Liu, H; Liu, S; Unterschemmann, K | 1 |
de Waal, EG; Kluin, PM; Leene, MJ; Slart, RH; Vellenga, E | 1 |
Duan, X; Li, J; Li, XF; Ma, Y; Postel, GC; Wang, F; Wang, X; Yin, X; Zhang, G; Zheng, H | 1 |
Galoforo, S; Grills, IS; Kane, JL; Krueger, SA; Marples, B; Wilson, GD; Wobb, J | 1 |
Aung, W; Endo, H; Fujibayashi, Y; Furukawa, T; Hasegawa, S; Inoue, M; Jin, ZH; Saga, T; Yoshii, Y; Yuan, Q; Zhang, MR | 1 |
Horiike, A; Inubushi, M; Koizumi, M; Nishio, M; Ohyanagi, F; Saga, T; Tanimoto, K; Yanagitani, N; Yoshikawa, K; Zhang, MR | 1 |
Das, M; Dingemans, AC; Even, AJG; Lambin, P; Mottaghy, FM; Oellers, M; Reymen, B; Troost, EGC; van Elmpt, W; Wildberger, JE; Zegers, CML | 1 |
Binns, D; Bressel, M; Graves, EE; Hicks, RJ; Le, QT; Peters, L; Rischin, D; Young, RJ | 1 |
Asamura, H; Fujii, H; Hayashi, Y; Kamiyama, I; Kinoshita, T; Ohtsuka, T | 1 |
Crukley, C; Desjardins, L; Hadway, J; Lee, TY; Morrison, L; Stewart, E; Wang, Y | 1 |
Bol, A; Di Perri, D; Geets, X; Hanin, FX; Janssens, G; Labar, D; Lee, JA; Robert, A; Sterpin, E | 2 |
Asada, Y; Iwakiri, T; Kawai, K; Kitamura, K; Koshimoto, C; Kuge, Y; Matsuura, Y; Sugita, C; Tamaki, N; Yamasaki, K; Yamashita, A; Zhao, S; Zhao, Y | 1 |
Bettinardi, V; Coliva, A; Compierchio, A; Doglioni, C; Fallanca, F; Gianolli, L; Incerti, E; Mapelli, P; Negri, G; Picchio, M; Rossetti, F; Savi, A | 1 |
Fan, B; Hu, M; Ma, L; Mu, D; Yang, G; Yu, J; Zhao, S; Zheng, J; Zhu, Y | 1 |
3 review(s) available for fluorodeoxyglucose f18 and azomycin
Article | Year |
---|---|
Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.
Topics: Acetates; Carcinoma, Renal Cell; Choline; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Staging; Nitroimidazoles; Positron-Emission Tomography; Radioimmunodetection; Radioimmunotherapy; Radiopharmaceuticals | 2006 |
Alternative PET tracers in head and neck cancer. A review.
Topics: Amino Acids; Antibodies, Monoclonal; Carbon Radioisotopes; Carcinoma, Squamous Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Misonidazole; Nitroimidazoles; Nucleosides; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
[Metabolic tailoring in radiotherapy for head and neck cancer].
Topics: Carcinoma, Squamous Cell; Cell Hypoxia; Clinical Trials as Topic; Diffusion Magnetic Resonance Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Misonidazole; Multimodal Imaging; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Tumor Burden | 2014 |
4 trial(s) available for fluorodeoxyglucose f18 and azomycin
Article | Year |
---|---|
Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog.
Topics: Adult; Aged; Astrocytoma; Biopsy; Brain Neoplasms; Carbon Isotopes; Cell Division; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia, Brain; Immunohistochemistry; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Nitroimidazoles; Oligodendroglioma; Positron-Emission Tomography; Protons; Radiopharmaceuticals | 2010 |
Standardized uptake value in high uptake area on positron emission tomography with 18F-FRP170 as a hypoxic cell tracer correlates with intratumoral oxygen pressure in glioblastoma.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Nitroimidazoles; Oxygen; Positron-Emission Tomography; Pressure | 2014 |
Prognostic value of (18) F-fluoroazomycin arabinoside PET/CT in patients with advanced non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Nitroimidazoles; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Nitroimidazoles; Oxygen; Oxygen Consumption; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Triazoles | 2016 |
38 other study(ies) available for fluorodeoxyglucose f18 and azomycin
Article | Year |
---|---|
The effect of tumor size on F-18-labeled fluorodeoxyglucose and fluoroerythronitroimidazole uptake in a murine sarcoma model.
Topics: Animals; Autoradiography; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Male; Mice; Mice, Inbred ICR; Necrosis; Nitroimidazoles; Sarcoma 180; Tomography, Emission-Computed | 1999 |
Adduct of 2-[18F]FDG and 2-nitroimidazole as a putative radiotracer for the detection of hypoxia with PET: synthesis, in vitro- and in vivo-characterization.
Topics: Animals; Carcinoma 256, Walker; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; HeLa Cells; Humans; In Vitro Techniques; Mammary Neoplasms, Experimental; Nitroimidazoles; Radiochemistry; Radiopharmaceuticals; Rats; Rats, Wistar; Tomography, Emission-Computed; Tumor Cells, Cultured | 2002 |
Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer.
Topics: Adult; Aged; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nitroimidazoles; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Evaluation of hypoxia in an experimental rat tumour model by [(18)F]fluoromisonidazole PET and immunohistochemistry.
Topics: Animals; Antibodies, Monoclonal; Carbonic Anhydrase III; Cell Hypoxia; Fluorodeoxyglucose F18; Heart; Immunoenzyme Techniques; Lung; Male; Misonidazole; Muscles; Nitroimidazoles; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Rats; Rhabdomyosarcoma | 2004 |
Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent mic
Topics: Animals; Autoradiography; Benzimidazoles; Cell Hypoxia; Coordination Complexes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Microscopy, Fluorescence; Misonidazole; Neoplasms; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Rats; Rats, Nude; Thiosemicarbazones; Transplantation, Heterologous | 2005 |
Dependence of FDG uptake on tumor microenvironment.
Topics: Animals; Autoradiography; Benzimidazoles; Bromodeoxyuridine; Cell Hypoxia; Cell Proliferation; Coloring Agents; Fluorodeoxyglucose F18; Glucose; Male; Mice; Mice, Nude; Neoplasms; Nitroimidazoles; Prostatic Neoplasms; Radiopharmaceuticals | 2005 |
Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.
Topics: Adult; Aged; Cell Hypoxia; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients.
Topics: Aged; Cell Hypoxia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2006 |
Measurement of hypoxia using invasive oxygen-sensitive electrode, pimonidazole binding and 18F-FDG uptake in anaemic or erythropoietin-treated mice bearing human glioma xenografts.
Topics: Anemia; Animals; Autoradiography; Electrodes; Erythropoietin; Fluorodeoxyglucose F18; Glioma; Hemoglobins; Humans; Hypoxia; Mice; Mice, Nude; Muscle, Skeletal; Neoplasm Transplantation; Nitroimidazoles; Recombinant Proteins; Transplantation, Heterologous | 2008 |
Experimental evaluation of functional imaging for radiotherapy.
Topics: Animals; Biomarkers, Tumor; Dose Fractionation, Radiation; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Neoplasms, Experimental; Neoplastic Stem Cells; Nitroimidazoles; Positron-Emission Tomography; Proportional Hazards Models; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Xenograft Model Antitumor Assays | 2007 |
Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.
Topics: Animals; Binding, Competitive; Biological Transport; Cell Count; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Mice; Neoplasms; Nitroimidazoles; Oxygen; Positron-Emission Tomography; Time Factors | 2008 |
Radio-copper-labeled Cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma model.
Topics: Animals; Autoradiography; Bromodeoxyuridine; Carcinoma, Lewis Lung; Cell Proliferation; Colony-Forming Units Assay; Coordination Complexes; Copper Radioisotopes; Disease Models, Animal; Fluorodeoxyglucose F18; Hypoxia; Image Processing, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Male; Mice; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Staining and Labeling; Thiosemicarbazones | 2009 |
Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer (14)C-EF3 in animal tumor models.
Topics: Animals; Carbon Radioisotopes; Disease Models, Animal; Fiducial Markers; Fluorodeoxyglucose F18; Hypoxia; Male; Mice; Neoplasms; Nitroimidazoles; Radionuclide Imaging | 2010 |
High 18F-FDG uptake in microscopic peritoneal tumors requires physiologic hypoxia.
Topics: Air; Animals; Autoradiography; Biological Transport; Carbon Dioxide; Cell Proliferation; Female; Fluorescent Antibody Technique; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; HT29 Cells; Humans; Hypoxia; Mice; Nitroimidazoles; Oxygen; Peritoneal Neoplasms; Respiration | 2010 |
Comparison of 18F-Fluoroerythronitroimidazole and 18F-fluorodeoxyglucose positron emission tomography and prognostic value in locally advanced non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2010 |
Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment.
Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cinnamates; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Head and Neck Neoplasms; Immunoenzyme Techniques; Lactates; Linear Models; Luminescent Measurements; Mice; Mice, Nude; Monocarboxylic Acid Transporters; Nitroimidazoles; Oxidation-Reduction; Symporters; Tumor Microenvironment; Uterine Cervical Neoplasms | 2011 |
(64)Cu-ATSM and (18)FDG PET uptake and (64)Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistry.
Topics: Animals; Autoradiography; Carcinoma; Cell Hypoxia; Coordination Complexes; Copper Radioisotopes; Dogs; Fluorodeoxyglucose F18; Immunohistochemistry; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Thiosemicarbazones | 2012 |
Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.
Topics: Animals; Biological Transport; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Misonidazole; Necrosis; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radioactive Tracers; Tumor Microenvironment | 2012 |
In vitro and in vivo evaluation of [(18)F]F-GAZ, a novel oxygen-mimetic azomycin-glucose conjugate, for imaging hypoxic tumor.
Topics: Animals; Biomimetic Materials; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Hypoxia imaging of uterine cervix carcinoma with (18)F-FETNIM PET/CT.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Imaging, Three-Dimensional; Middle Aged; Multimodal Imaging; Nitroimidazoles; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Biological characteristics of intratumoral [F-18]‑fluoromisonidazole distribution in a rodent model of glioma.
Topics: Animals; Autoradiography; Biological Transport; Brain Neoplasms; Cell Hypoxia; Cell Proliferation; Fluorodeoxyglucose F18; Glioma; Glucose; Glucose Transporter Type 1; Hexokinase; Hypoxia-Inducible Factor 1; Ki-67 Antigen; Male; Misonidazole; Nitroimidazoles; Rats; Rats, Wistar; Tissue Distribution | 2013 |
PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nitroimidazoles; Positron-Emission Tomography; Tumor Burden | 2013 |
Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Nitroimidazoles; Positron-Emission Tomography; Rats; Survival Analysis | 2013 |
PET imaging of tumor hypoxia using 18F-labeled pimonidazole.
Topics: Animals; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Mice, Nude; Nitroimidazoles; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tumor Cells, Cultured | 2013 |
18FDG, [18F]FLT, [18F]FAZA, and 11C-methionine are suitable tracers for the diagnosis and in vivo follow-up of the efficacy of chemotherapy by miniPET in both multidrug resistant and sensitive human gynecologic tumor xenografts.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autoradiography; Carbon Radioisotopes; Cell Line, Tumor; Dideoxynucleosides; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flow Cytometry; Fluorodeoxyglucose F18; Follow-Up Studies; Genital Neoplasms, Female; Humans; Methionine; Mice; Mice, SCID; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
18F-FAZA PET imaging response tracks the reoxygenation of tumors in mice upon treatment with the mitochondrial complex I inhibitor BAY 87-2243.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Nude; Nitroimidazoles; Oxadiazoles; Positron-Emission Tomography; Prostatic Neoplasms; Pyrazoles; Radiopharmaceuticals; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
18F-FDG PET increases visibility of bone lesions in relapsed multiple myeloma: is this hypoxia-driven?
Topics: Basic Helix-Loop-Helix Transcription Factors; Bone Marrow; Bone Neoplasms; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Multiple Myeloma; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2015 |
The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study.
Topics: Animals; Blood Glucose; Body Weight; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Diet; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Microenvironment | 2015 |
The Effects of Pulsed Radiation Therapy on Tumor Oxygenation in 2 Murine Models of Head and Neck Squamous Cell Carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Coloring Agents; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Heterografts; Mice; Mice, Nude; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles; Oxygen Consumption; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2015 |
A limited overlap between intratumoral distribution of 1-(5-fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole and copper-diacetyl-bis[N(4)-methylthiosemicarbazone].
Topics: Animals; Biomarkers, Tumor; Cell Hypoxia; Cell Line, Tumor; Cell Tracking; Coordination Complexes; Fluorodeoxyglucose F18; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Mice; Neoplasms; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Radiography; Thiosemicarbazones; Xenograft Model Antitumor Assays | 2015 |
Quantitative and qualitative analysis of [(18)F]FDG and [(18)F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcome.
Topics: Adult; Aged; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nitroimidazoles; Papillomavirus Infections; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Prognostic significance of hypoxic PET using (18)F-FAZA and (62)Cu-ATSM in non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Coordination Complexes; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Thiosemicarbazones | 2016 |
Assessment of intratumor hypoxia by integrated 18F-FDG PET / perfusion CT in a liver tumor model.
Topics: Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Liver Neoplasms; Male; Neovascularization, Pathologic; Nitroimidazoles; Oxygen Consumption; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rabbits | 2017 |
Evolution of [
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage | 2017 |
Altered glucose metabolism and hypoxic response in alloxan-induced diabetic atherosclerosis in rabbits.
Topics: Alloxan; Animals; Apoptosis; Atherosclerosis; Autoradiography; Body Weight; Cluster Analysis; Diabetes Mellitus, Experimental; Diet, High-Fat; Electrophoresis, Capillary; Femoral Artery; Fluorodeoxyglucose F18; Glucose; Glycolysis; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Macrophages; Mass Spectrometry; Metabolomics; Microscopy, Fluorescence; Nitroimidazoles; Principal Component Analysis; Rabbits | 2017 |
Correlation analysis of [
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Small Cell Lung Carcinoma | 2017 |
18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals | 2018 |
Correlation of hypoxia as measured by fluorine-18 fluoroerythronitroimidazole (
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Hypoxia; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2020 |